Skyrizi is available in multiple forms, including single-dose prefilled pens and single-dose prefilled syringes. The typical dosages of Skyrizi may vary depending on which condition is being treated.

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

Lynozyfic (linvoseltamab-gcpt) is a prescription injection medicine for people with a type of blood cancer called multiple myeloma, whose cancer has come back (relapsed) or worsened (refractory) after ...

Rituxan, prescribed for rheumatoid arthritis and certain cancers, carries a risk of infusion reactions, which can range from mild to severe and require close monitoring by a healthcare professional.

A new way to get vitamins is popping up all over Long Island — not from fruits and vegetables or pharmacies, but in sleek, spa-like venues where nurses pump nutrients from an IV bag directly into ...

Deaths in Mexico put spotlight on vitamin IV industry growing in Arizona. What’s really in your vitamin drip? Experts urge ...

Donanemab is also given by IV infusion, but just once a month. In the results presented Wednesday, the weekly shot form of Leqembi was shown to reduce those plaques by about 14% more than the IV form ...

Phase 3 trial evaluated two subcutaneous BRIUMVI dosing regimens; administration every 2 months or every 3 monthsTop-line data expected year-end ...

Omvoh (mirikizumab-mrkz) is a brand-name drug that’s prescribed for moderate to severe active ulcerative colitis and moderate to severe active Crohn’s disease in adults. It is available as an ...

Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.

solution in a single-use Sensoready pen solution in a single-use UnoReady pen solution in a single-use prefilled syringe Cosentyx also comes as a solution in a single-use vial that’s given as an ...

The Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the disease, may be able to be given as a set of two weekly shots at home, a study from drugmaker Eisai suggests, ...